2021 SPEAKERS

 

 

Upendra Abhyankar, Executive Director of Patient Safety Solutions, Labcorp Drug Development

Upendra Abhyankar | Executive Director of Patient Safety Solutions | Labcorp Drug Development » speaking at Drug Safety USA

Carlos Aceves-González, Associate Professor, UNiversidad de Guadalajara

Carlos Aceves-González | Associate Professor | UNiversidad de Guadalajara » speaking at Drug Safety USA

Omar Aimer, Pharmacovigilance Specialist, Brunel Canada

Omar Aimer | Pharmacovigilance Specialist | Brunel Canada » speaking at Drug Safety USA

Wassim Aldairy, VP, Pharmacovigilance, Mersana Therapeutics, Inc.

Wassim Aldairy | VP, Pharmacovigilance | Mersana Therapeutics, Inc. » speaking at Drug Safety USA

Aysha Amman, Associate Director, Pharmacovigilance Officer, Local Safety, Teva Pharmaceuticals

Aysha Amman | Associate Director, Pharmacovigilance Officer, Local Safety | Teva Pharmaceuticals » speaking at Drug Safety USA

Rawad Antoun, Director, Gcsp Regions Lead, Americas, CSL Behring

Rawad Antoun | Director, Gcsp Regions Lead, Americas | CSL Behring » speaking at Drug Safety USA

Greg Ball, Senior Principal Statistician, Merck

Greg Ball | Senior Principal Statistician | Merck » speaking at Drug Safety USA

Khaudeja Bano, Executive Medical Director, Combination Product Safety Head, Amgen

Khaudeja Bano | Executive Medical Director, Combination Product Safety Head | Amgen » speaking at Drug Safety USA

Jennifer Barnes, Pharmacovigilance Manager, Compliance, Teva Pharmaceuticals

Jennifer Barnes | Pharmacovigilance Manager, Compliance | Teva Pharmaceuticals » speaking at Drug Safety USA

Victoria Bartasek, Senior Associate Director, Global Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG

Victoria Bartasek | Senior Associate Director, Global Pharmacovigilance | Boehringer Ingelheim Pharma GmbH & Co. KG » speaking at Drug Safety USA

Emmanuel "Manny" Belabe, Associate Vice President, Safety Business Unit, ArisGlobal

Emmanuel "Manny" Belabe | Associate Vice President, Safety Business Unit | ArisGlobal » speaking at Drug Safety USA

Kapil Bhutada, Director, PV Compliance and Training, Medicago

Kapil Bhutada | Director, PV Compliance and Training | Medicago » speaking at Drug Safety USA

Amanda Bowles, Consulting Managing Director, Deloitte Consulting

Amanda Bowles | Consulting Managing Director | Deloitte Consulting » speaking at Drug Safety USA

Jim Buchanan, Clinician, Covilance

Jim Buchanan | Clinician | Covilance » speaking at Drug Safety USA

Siva Kumar Buddha, Global Safety Physician Manager Product Safety and Risk Management, Viatris- Mylan

Siva Kumar Buddha | Global Safety Physician Manager Product Safety and Risk Management | Viatris- Mylan » speaking at Drug Safety USA

Glenn Carroll, Principal, Life Sciences, Deloitte Consulting

Glenn Carroll | Principal, Life Sciences | Deloitte Consulting » speaking at Drug Safety USA

Shaun Comfort, Principal Science Enablement Director, Genentech

Shaun Comfort | Principal Science Enablement Director | Genentech » speaking at Drug Safety USA

Jacqueline Corrigan-Curay, Director, Office of Medical Policy, Center for Drug Evaluation and Research, FDA

Jacqueline Corrigan-Curay | Director, Office of Medical Policy, Center for Drug Evaluation and Research | FDA » speaking at Drug Safety USA

Cristina Damatarca, President, SafePharm LLC

Cristina Damatarca | President | SafePharm LLC » speaking at Drug Safety USA

Jeffrey DiFrancesco, Executive Vice President & Chief Officer of Life Science, Tabula Rasa Healthcare

Jeffrey DiFrancesco | Executive Vice President & Chief Officer of Life Science | Tabula Rasa Healthcare » speaking at Drug Safety USA

Kal Elhoregy, Director, Risk Evaluation and Mitigation Strategy (REMS), Amneal Pharmaceuticals

Kal Elhoregy | Director, Risk Evaluation and Mitigation Strategy (REMS) | Amneal Pharmaceuticals » speaking at Drug Safety USA

Birol Emir, Sr. Director, RWE Statistics group Lead, Pfizer

Birol Emir | Sr. Director, RWE Statistics group Lead | Pfizer » speaking at Drug Safety USA

Michael Feehan, VP Consulting, Real World Evidence – Regulatory & Safety, Kantar Health

Michael Feehan | VP Consulting, Real World Evidence – Regulatory & Safety | Kantar Health » speaking at Drug Safety USA

Tracy Follansbee, Risk, Regulatory and Safety Manager, Elsevier

Tracy Follansbee | Risk, Regulatory and Safety Manager | Elsevier » speaking at Drug Safety USA

Jacqueline Gerena, Director, Program Management (REMS & RMP), Aimmune Therapeutics

Jacqueline Gerena | Director, Program Management (REMS & RMP) | Aimmune Therapeutics » speaking at Drug Safety USA

Coryandar Gilvary, Chief Data Scientisit, OneThree Biotech

Coryandar Gilvary | Chief Data Scientisit | OneThree Biotech » speaking at Drug Safety USA

Michael Glaser, Safety Innovation Technology Director, GSK

Michael Glaser | Safety Innovation Technology Director | GSK » speaking at Drug Safety USA

Lana Gloukhova, Global Head Of Regions, PV, CSL Behring

Lana Gloukhova | Global Head Of Regions, PV | CSL Behring » speaking at Drug Safety USA

Aaron Goodstein, Senior Director, Medical Safety Strategy and Operations, Johnson and Johnson Medical Devices

Aaron Goodstein | Senior Director, Medical Safety Strategy and Operations | Johnson and Johnson Medical Devices » speaking at Drug Safety USA

Kishore Gopu, Senior Director, REMS Operations, Teva Pharmaceuticals

Kishore Gopu | Senior Director, REMS Operations | Teva Pharmaceuticals » speaking at Drug Safety USA

Bill Haddock, Head Of Safety, Ovid Therapeutics

Bill Haddock | Head Of Safety | Ovid Therapeutics » speaking at Drug Safety USA

Rave Harpaz, Senior Director Research and Data Science, Oracle Health Sciences

Rave Harpaz | Senior Director Research and Data Science | Oracle Health Sciences » speaking at Drug Safety USA

Peter Hawkins, Senior Director, Head Of Rare Genetic Disease Risk Management, Agios Pharmaceuticals

Peter Hawkins | Senior Director, Head Of Rare Genetic Disease Risk Management | Agios Pharmaceuticals » speaking at Drug Safety USA

Martin Holm-Petersen, CEO, Insife

Martin Holm-Petersen | CEO | Insife » speaking at Drug Safety USA

Pooja Jain, Senior Product Manager, Life Sciences, Elsevier

Pooja Jain | Senior Product Manager, Life Sciences | Elsevier » speaking at Drug Safety USA

Stephan Jarpa, Director General, Agencia InHouse

Stephan Jarpa | Director General | Agencia InHouse » speaking at Drug Safety USA

Kedar Joshi, Associate Vice President - Global Client Partner, Indegene

Kedar Joshi | Associate Vice President - Global Client Partner | Indegene » speaking at Drug Safety USA

Prashant Joshi, Executive Director of Drug Safety, Labcorp Drug Development

Prashant Joshi | Executive Director of Drug Safety | Labcorp Drug Development » speaking at Drug Safety USA

Raymond Kassekert, Senior Director and Head, PV Systems, GlaxoSmithKline

Raymond Kassekert | Senior Director and Head, PV Systems | GlaxoSmithKline » speaking at Drug Safety USA

Dinesh Kasthuril, Head of Global Client Relations & Project Management, Patient Safety Solution, Labcorp Drug Development

Dinesh Kasthuril | Head of Global Client Relations & Project Management, Patient Safety Solution | Labcorp Drug Development » speaking at Drug Safety USA

Leandre Kenmogne Cheteu, R&D Researcher, Zhejiang Sci-Tech University

Leandre Kenmogne Cheteu | R&D Researcher | Zhejiang Sci-Tech University » speaking at Drug Safety USA

Rahul Khajuria, Senior Director, Global Head Of Drug Safety Systems And Analytics, United Therapeutics

Rahul Khajuria | Senior Director, Global Head Of Drug Safety Systems And Analytics | United Therapeutics » speaking at Drug Safety USA

Wasim Khan, Global Safety Officer, Immuno-oncology Therapeutic Area, Amgen

Wasim Khan | Global Safety Officer, Immuno-oncology Therapeutic Area | Amgen » speaking at Drug Safety USA

Jerry Kounga, Investigational Drug Lead Pharmacist, Ascension Health Wisconsin

Jerry Kounga | Investigational Drug Lead Pharmacist | Ascension Health Wisconsin » speaking at Drug Safety USA

Stephen Kuske, Vice President, Global Head of Pharmacovigilance Operations, sanofi

Stephen Kuske | Vice President, Global Head of Pharmacovigilance Operations | sanofi » speaking at Drug Safety USA

Anna Lukyanova, COO, Arriello

Anna Lukyanova | COO | Arriello » speaking at Drug Safety USA

Bruno Mendez, VP, Global quality PV, Sanofi Pasteur

Bruno Mendez | VP, Global quality PV | Sanofi Pasteur » speaking at Drug Safety USA

Madhu Mondal, Senior Director, Safety Assessment, Cerevel Therapeutics

Madhu Mondal | Senior Director, Safety Assessment | Cerevel Therapeutics » speaking at Drug Safety USA

Deanna Montes De Oca, Sr.Director, PV Operations-Global Case Management, Moderna Therapeutics

Deanna Montes De Oca | Sr.Director, PV Operations-Global Case Management | Moderna Therapeutics » speaking at Drug Safety USA

Raj More, Chief Architect & CEO, RxLogix Corporation

Raj More | Chief Architect & CEO | RxLogix Corporation » speaking at Drug Safety USA

Kishan Nandha, Manager, Pharmacovigilance Quality Assurance, Astellas Pharma

Kishan Nandha | Manager, Pharmacovigilance Quality Assurance | Astellas Pharma » speaking at Drug Safety USA

Oyinkansola Odebo, Assistant Director Drug Safety, Supernus Pharmaceutical

Oyinkansola Odebo | Assistant Director Drug Safety | Supernus Pharmaceutical » speaking at Drug Safety USA

Nneka Okere, Director, Pharmacovigilance, Nurix Therapeutics

Nneka Okere | Director, Pharmacovigilance | Nurix Therapeutics » speaking at Drug Safety USA

Joe O'Rourke, Vice President, Business Development, WCG Clinical

Joe O'Rourke | Vice President, Business Development | WCG Clinical » speaking at Drug Safety USA

Bruce Palsulich, Vice President of Safety Product Strategy, Oracle Health Sciences

Bruce Palsulich | Vice President of Safety Product Strategy | Oracle Health Sciences » speaking at Drug Safety USA

Krishna Patel, Partner, Prudentia Group LLC

Krishna Patel | Partner | Prudentia Group LLC » speaking at Drug Safety USA

Amanda Paulson, Informatics Specialist, University of California San Francisco

Amanda Paulson | Informatics Specialist | University of California San Francisco » speaking at Drug Safety USA

John Peabody, President, QURE Healthcare

John Peabody | President | QURE Healthcare » speaking at Drug Safety USA

Vladimir Penkrat, Associate Vice President - Global Head of Safety & Regulatory Affairs, Indegene Inc.

Vladimir Penkrat | Associate Vice President - Global Head of Safety & Regulatory Affairs | Indegene Inc. » speaking at Drug Safety USA

John Price, Pharmaceutical Physician Consultant, Patient Safety, Pharmacovigilance and Regulatory Affairs, Advisory Board Member, Arriello

John Price | Pharmaceutical Physician Consultant, Patient Safety, Pharmacovigilance and Regulatory Affairs, Advisory Board Member | Arriello » speaking at Drug Safety USA

Rakesh Raman, Senior Director, Medical Safety Science, Mirum Pharmaceuticals

Rakesh Raman | Senior Director, Medical Safety Science | Mirum Pharmaceuticals » speaking at Drug Safety USA

Angela Caro Rojas, President, Colombian Pharmacovigilance Association

Angela Caro Rojas | President | Colombian Pharmacovigilance Association » speaking at Drug Safety USA

Dr. Md Abu Zafor Sadek, Marketing Manager, UniMed UniHealth Pharmaceuticals

Dr. Md Abu Zafor Sadek | Marketing Manager | UniMed UniHealth Pharmaceuticals » speaking at Drug Safety USA

Satya Sagi, Founder & CEO, Techsol Corporation

Satya Sagi | Founder & CEO | Techsol Corporation » speaking at Drug Safety USA

Parivesh Sakalle, Regulatory Compliance Manager, Sanofi-Aventis

Parivesh Sakalle | Regulatory Compliance Manager | Sanofi-Aventis » speaking at Drug Safety USA

Philip Schneider, Advisory Board Chair, Alliance for Safe Biologic Medicines

Philip Schneider | Advisory Board Chair | Alliance for Safe Biologic Medicines » speaking at Drug Safety USA

Jeanne Schow, Vice President Sales and US Head Business Development, APCER Life Sciences

Jeanne Schow | Vice President Sales and US Head Business Development | APCER Life Sciences » speaking at Drug Safety USA

Vipin Sethi, Head Of Global Pharmacovigilance And Medical Affairs, Cadila Pharmaceuticals

Vipin Sethi | Head Of Global Pharmacovigilance And Medical Affairs | Cadila Pharmaceuticals » speaking at Drug Safety USA

Kan Shao, Associate Professor Of Environmental And Occupational Health, Indiana University

Kan Shao | Associate Professor Of Environmental And Occupational Health | Indiana University » speaking at Drug Safety USA

Simon Sinclair, Chief Safety Officer, Reckitt Benckiser plc

Simon Sinclair | Chief Safety Officer | Reckitt Benckiser plc » speaking at Drug Safety USA

Annette Stemhagen, SVP & Chief Science Officer, Safety, Epidemiology, Registries & Risk Management, UBC

Annette Stemhagen | SVP & Chief Science Officer, Safety, Epidemiology, Registries & Risk Management | UBC » speaking at Drug Safety USA

Jeff Tucker, Senior Director, RxLogix Corporation

Jeff Tucker | Senior Director | RxLogix Corporation » speaking at Drug Safety USA

Dennis Vargo, Vice President, Head Of Drug Safety And Pharmacovigilance, Akebia Therapeutics , Inc.

Dennis Vargo | Vice President, Head Of Drug Safety And Pharmacovigilance | Akebia Therapeutics , Inc. » speaking at Drug Safety USA

Marcin von Grotthuss, Principal Scientist, Investigative Toxicology, Takeda

Marcin von Grotthuss | Principal Scientist, Investigative Toxicology | Takeda » speaking at Drug Safety USA

Max Waschbusch, TA Head Cardiovascular and Metabolism, CSL Behring

Max Waschbusch | TA Head Cardiovascular and Metabolism | CSL Behring » speaking at Drug Safety USA

Alan White, CEO, Arriello

Alan White | CEO | Arriello » speaking at Drug Safety USA

Beena Wood, VP, Safety Product Management, ArisGlobal

Beena Wood | VP, Safety Product Management | ArisGlobal » speaking at Drug Safety USA

Richard C. Zink, Adjunct Professor of Biostatistics, The University of North Carolina at Chapel Hill

Richard C. Zink | Adjunct Professor of Biostatistics | The University of North Carolina at Chapel Hill » speaking at Drug Safety USA

Patricia Zuluaga Arias, Vice President, Coordinator of Academic Committee, Colombian Pharmacovigilance Association

Patricia Zuluaga Arias | Vice President, Coordinator of Academic Committee | Colombian Pharmacovigilance Association » speaking at Drug Safety USA

 

 

 

Get Involved At Drug Safety Congress Americas

 

To Sponsor Or Exhibit


Semen Sen
Semen.sen@terrapinn.com
t/ +1 646 619 1793

 

 

To Speak


Semen Sen
semen.sen@terrapinn.com
t/ +1 646 619 1793

 

 

Marketing & Press Opportunities


Taylor Post
taylor.post@terrapinn.com
t/ +1 646 619 1785